NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Sunflower Therapeutics

Sunflower Therapeutics

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://sunflowertx.com/

Last Round

Grant

Sep 3, 2025

Total Funding Raised

$22.46M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Sunflower Therapeutics is a biotechnology company that develops next-generation, automated, and fully-integrated protein manufacturing solutions to simplify the process from discovery to full-scale biomanufacturing.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Smart Manufacturing

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

biomanufacturingprotein manufacturingbiologics productionbiotech equipmentautomated bioreactordecentralized manufacturingbiotech hardwarebioprocess automationmodular manufacturingmicrobial strain engineeringfermentation optimizationlab-in-a-boxalternative proteinmedical countermeasures

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sunflower Therapeutics Comparables

Compare Sunflower Therapeutics with similar companies based on industry and business-model similarity.

Sunflower Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Sunflower Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 3, 2025
SAFEDec 3, 2024
GrantJan 18, 2023
VC RoundAug 17, 2021
GrantFeb 1, 2021

Key People

Founding team and executive leadership

Kerry Love

Founder, CEO President

Founding Team

Tom Heer

Chief Financial Officer

Executive Team

Sunflower Therapeutics Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 12, 2026

    Partnered with MATSUBO Corporation for Japanese market expansion.

  • Jan 26, 2026

    Added CESCO Custom Equipment Solutions Co. as a customer.

Sunflower Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Sunflower Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Sunflower Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range18
Year Founded2018
Last FundingSep 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.